{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:37:47Z","timestamp":1782207467771,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00393-017-0356-7","type":"journal-article","created":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T08:35:45Z","timestamp":1502267745000},"page":"621-628","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy and safety of sofosbuvir-based, interferon-free therapy","Wirksamkeit und Sicherheit der Sofosbuvir-basierten Interferon-freien Therapie"],"prefix":"10.1007","volume":"77","author":[{"given":"A. A.","family":"Shahin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. S.","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"issue":"Suppl 1","key":"356_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1478-3231.2008.01934.x","volume":"29","author":"D Lavanchy","year":"2009","unstructured":"Lavanchy D (2009) The global burden of hepatitis C. Liver Int 29(Suppl 1):74\u201381","journal-title":"Liver Int"},{"key":"356_CR2","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1002\/1529-0131(199910)42:10<2204::AID-ANR24>3.0.CO;2-D","volume":"42","author":"P Cacoub","year":"1999","unstructured":"Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P (1999) Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum 42:2204\u20132212","journal-title":"Arthritis Rheum"},{"issue":"4\u20135","key":"356_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1177\/0961203314556140","volume":"24","author":"E Rosenthal","year":"2015","unstructured":"Rosenthal E, Cacoub P (2015) Extrahepatic manifestations in chronic hepatitis C virus carriers. Lupus 24(4\u20135):469\u2013482","journal-title":"Lupus"},{"key":"356_CR4","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S1473-3099(05)70053-0","volume":"5","author":"D Sansonno","year":"2005","unstructured":"Sansonno D, Dammacco F (2005) Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 5:227\u2013236","journal-title":"Lancet Infect Dis"},{"key":"356_CR5","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","volume":"379","author":"M Ramos-Casals","year":"2012","unstructured":"Ramos-Casals M, Stone JH, Cid MC, Bosch X (2012) The cryoglobulinaemias. Lancet 379:348\u2013360","journal-title":"Lancet"},{"key":"356_CR6","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1046\/j.1365-2893.2002.00364.x","volume":"9","author":"T Poynard","year":"2002","unstructured":"Poynard T, Cacoub P, Ratziu V et\u00a0al (2002) Fatigue in patients with chronic hepatitis C. J\u00a0Viral Hepat 9:295\u2013303","journal-title":"J Viral Hepat"},{"issue":"6","key":"356_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.semarthrit.2003.12.006","volume":"33","author":"I Rosner","year":"2004","unstructured":"Rosner I, Rozenbaum M, Toubi E, Kessel A, Naschitz JE, Zuckerman E (2004) The case for hepatitis C arthritis. Semin Arthritis Rheum 33(6):375\u2013387","journal-title":"Semin Arthritis Rheum"},{"key":"356_CR8","doi-asserted-by":"publisher","first-page":"e00008","DOI":"10.1136\/rmdopen-2014-000008","volume":"1","author":"LH Calabrese","year":"2015","unstructured":"Calabrese LH, Cacoub PP (2015) For patients with rheumatic disease and hepatitis C infection: the end of interferon. RMD Open 1:e8. https:\/\/doi.org\/10.1136\/rmdopen-2014-000008","journal-title":"RMD Open"},{"issue":"5","key":"356_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.jhep.2014.10.044","volume":"62","author":"PJ Ruane","year":"2015","unstructured":"Ruane PJ, Ain D, Stryker R, Meshrekey R, Soliman M, Wolfe PR, Riad J, Mikhail S, Kersey K, Jiang D, Massetto B, Doehle B, Kirby BJ, Knox SJ, McHutchison JG, Symonds WT (2015) Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestry. J\u00a0Hepatol 62(5):1040\u20131046","journal-title":"J Hepatol"},{"issue":"1","key":"356_CR10","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","volume":"63","author":"European Association for Study of Liver","year":"2015","unstructured":"European Association for Study of Liver (2015) EASL recommendations on treatment of hepatitis C 2015. J\u00a0Hepatol 63(1):199\u2013236","journal-title":"J Hepatol"},{"issue":"10","key":"356_CR11","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1136\/annrheumdis-2015-208339","volume":"75","author":"D Saadoun","year":"2016","unstructured":"Saadoun D, Thibault V, Si ASN, Alric L, Mallet M, Guillaud C, Izzedine H, Plaisier A, Fontaine H, Costopoulos M, Le Garff-Tavernier M, Hezode C, Pol S, Musset L, Poynard T, Cacoub P (2016) Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study. Ann Rheum Dis 75(10):1777\u20131782","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"356_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/rheumatology\/keu271","volume":"53","author":"L Quartuccio","year":"2014","unstructured":"Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM, Zoheir MN, El-Menyawi MA, Salem MN, Sansonno D, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Scarpato S, Pipitone N, Salvarani C, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Sebastiani M, Tomsic M, Tavoni A, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Zignego AL, Ferri C, Monti G, Pietrogrande M, Bombardieri S, Galli M, De Vita S (2014) Validation of the classification criteria for cryoglobulinaemic vasculitis. Rheumatology (Oxford) 53(12):2209\u20132213","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"356_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a\u00a0prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44\u201348","journal-title":"Arthritis Rheum"},{"issue":"4","key":"356_CR14","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0022-3999(02)00392-6","volume":"54","author":"HJ Michielsen","year":"2003","unstructured":"Michielsen HJ, De Vries J, Van Heck GL (2003) Psychometric qualities of a\u00a0brief self-rated fatigue measure: the fatigue assessment scale. J\u00a0Psychosom Res 54(4):345\u2013352","journal-title":"J Psychosom Res"},{"issue":"989","key":"356_CR15","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1136\/ard.2005.051078","volume":"84","author":"O Flossmann","year":"2008","unstructured":"Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, Westman K, Luqmani R (2008) Development of comprehensive disease assessment in systemic vasculitis. Postgrad Med\u00a0J 84(989):143\u2013152","journal-title":"Postgrad Med J"},{"issue":"3","key":"356_CR16","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","volume":"116","author":"D Saadoun","year":"2010","unstructured":"Saadoun D, Resche-Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Copp\u00e9r\u00e9 B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P (2010) Rituximab plus Peg-interferon-alpha\/ribavirin compared with Peg-interferon-alpha\/ribavirin in hepatitis C\u2011related mixed cryoglobulinemia. Blood 116(3):326\u2013334","journal-title":"Blood"},{"issue":"4","key":"356_CR17","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/hep.22759","volume":"49","author":"MG Ghany","year":"2009","unstructured":"Ghany MG, Strader DB, Thomas DL, Seeff LB (2009) American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology 49(4):1335\u20131374","journal-title":"Hepatology"},{"issue":"5","key":"356_CR18","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/apt.12601","volume":"39","author":"RS Koff","year":"2014","unstructured":"Koff RS (2014) Review article: the efficacy and safety of sofosbuvir, a\u00a0novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection. Aliment Pharmacol Ther 39(5):478\u2013487","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"356_CR19","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2893.2009.01087.x","volume":"16","author":"L Castera","year":"2009","unstructured":"Castera L (2009) Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J\u00a0Viral Hepat 16(5):300\u2013314","journal-title":"J Viral Hepat"},{"issue":"2","key":"356_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1002\/hep.28297","volume":"63","author":"ME Sise","year":"2016","unstructured":"Sise ME, Bloom AK, Wisocky J, Lin MV, Gustafson JL, Lundquist AL, Steele D, Thiim M, Williams WW, Hashemi N, Kim AY, Thadhani R, Chung RT (2016) Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents. Hepatology 63(2):408\u2013417","journal-title":"Hepatology"},{"issue":"5","key":"356_CR21","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1002\/hep.28753","volume":"64","author":"L Gragnani","year":"2016","unstructured":"Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, Perez M, Ceccotti G, Colantuono S, Mitrevski M, Stasi C, Del Padre M, Monti M, Gianni E, Pulsoni A, Fiorilli M, Casato M, Zignego AL (2016) Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology 64(5):1473\u20131482","journal-title":"Hepatology"},{"issue":"11","key":"356_CR22","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1002\/art.22168","volume":"54","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P (2006) Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a\u00a0long-term followup study. Arthritis Rheum 54(11):3696\u20133706 (Nov)","journal-title":"Arthritis Rheum"},{"issue":"4","key":"356_CR23","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.27623","volume":"61","author":"L Gragnani","year":"2015","unstructured":"Gragnani L, Fognani E, Piluso A, Boldrini B, Urraro T, Fabbrizzi A, Stasi C, Ranieri J, Monti M, Arena U, Iannacone C, Laffi G, Zignego AL, MaSVE Study Group. (2015) Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a\u00a0prospective, controlled, open-label, cohort study. Hepatology 61(4):1145\u20131153","journal-title":"Hepatology"},{"issue":"1","key":"356_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejr.2015.02.002","volume":"38","author":"K Ayman","year":"2016","unstructured":"Ayman K, Fawzy SM, Talaat FM, Aziz MS (2016) Efficacy and safety of combined pegylated interferon\/ribavirin therapy in the management of rheumatological manifestations of chronic HCV patients. Egypt Rheumatol 38(1):53\u201359","journal-title":"Egypt Rheumatol"},{"key":"356_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12674","author":"M Dirks","year":"2017","unstructured":"Dirks M, Pflugrad H, Haag K, Tillmann HL, Wedemeyer H, Arvanitis D, Hecker H, Tountopoulou A, Goldbecker A, Worthmann H, Weissenborn K (2017) Persistent neuropsychiatric impairment in HCV patients despite clearance of the virus?! J\u00a0Viral Hepat. https:\/\/doi.org\/10.1111\/jvh.12674","journal-title":"J Viral Hepat"},{"issue":"10","key":"356_CR26","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1128\/JVI.78.10.5170-5183.2004","volume":"78","author":"DM Forton","year":"2004","unstructured":"Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC (2004) Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J\u00a0Virol 78(10):5170\u20135183","journal-title":"J Virol"},{"issue":"5","key":"356_CR27","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2012.06.030","volume":"57","author":"S Sarkar","year":"2012","unstructured":"Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH (2012) Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J\u00a0Hepatol 57(5):946\u2013952","journal-title":"J Hepatol"},{"issue":"2","key":"356_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jhep.2014.04.003","volume":"61","author":"ZM Younossi","year":"2014","unstructured":"Younossi ZM, Stepanova M, Zeuzem S, Dusheiko G, Esteban R, Hezode C, Reesink HW, Weiland O, Nader F, Hunt SL (2014) Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: the VALENCE study. J\u00a0Hepatol 61(2):228\u2013234","journal-title":"J Hepatol"},{"key":"356_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/910519","author":"D Isaacs","year":"2013","unstructured":"Isaacs D, Abdelaziz N, Keller M, Tibble J, Haq I (2013) Measuring the response of extrahepatic symptoms and quality of life to antiviral treatment in patients with hepatitis C. Hepat Res Treat. https:\/\/doi.org\/10.1155\/2013\/910519","journal-title":"Hepat Res Treat"},{"issue":"1","key":"356_CR30","first-page":"3","volume":"48","author":"C T\u0103n\u0103sescu","year":"2010","unstructured":"T\u0103n\u0103sescu C, Ionescu R (2010) Treatment of extrahepatic manifestations of chronic hepatitis C viral infection \u2013 a challenge. Rom J Intern Med 48(1):3\u20137","journal-title":"Rom J Intern Med"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-017-0356-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0356-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-017-0356-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T17:08:22Z","timestamp":1659114502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-017-0356-7"}},"subtitle":["The Management of rheumatologic extrahepatic manifestations associated with chronic hepatitis C\u00a0virus infection","Management rheumatologischer extrahepatischer Manifestationen in Zusammenhang mit chronischer Hepatitis-C-Virus-Infektion"],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1007\/s00393-017-0356-7","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]},"assertion":[{"value":"9 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"A.A.\u00a0Shahin, H.S.\u00a0Zayed, M.\u00a0Said and S.A.\u00a0Amer declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}